Literature DB >> 9366057

Signal transduction pathways for serotonin as an intestinal secretagogue.

M B Hansen1, E Skadhauge.   

Abstract

This review presents a signal transduction pathways for serotonin (5-hydroxytryptamine, 5-HT) as an intestinal secretagogue and some recently published related findings. 5-HT is a secretagogue in the small and large intestine of all studied species including pig and man. 5-HT mediates intestinal secretion through activation of at least the epithelial 5-HT2, and neuronal 5-HT3, and 5-HT4 receptors in the submucosal plexus, including a reflex arc. 5-HT activates both a cholinergic and a non-cholinergic pathway in its secretory response. Intracellular mediators include at least eicosanoids (prostaglandin E2), calcium, phosphoinositols (1,4,5-inositol trisphosphate) and maybe nitric oxide and cyclic nucleotides. Pig small intestine appears to be an appropriate model for the human small intestine with respect to the signal transduction pathways for 5-HT as an intestinal secretagogue. Species and segmental differences in the signal transduction pathways for 5-HT as an intestinal secretagogues are discussed together with related news on 5-HT receptors, 5-HT antagonists in clinical use, the enteric nervous system, and intracellular mediators.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366057     DOI: 10.1016/s0300-9629(97)00085-6

Source DB:  PubMed          Journal:  Comp Biochem Physiol A Physiol        ISSN: 1096-4940


  18 in total

1.  Activation of submucosal 5-HT(3) receptors elicits a somatostatin-dependent inhibition of ion secretion in rat colon.

Authors:  N Yang; S M Liu; L F Zheng; T Ji; Y Li; X L Mi; H Xue; W Ren; J D Xu; X H Zhang; L S Li; Y Zhang; J X Zhu
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

2.  Human-derived gut microbiota modulates colonic secretion in mice by regulating 5-HT3 receptor expression via acetate production.

Authors:  Yogesh Bhattarai; Bradley A Schmidt; David R Linden; Eric D Larson; Madhusudan Grover; Arthur Beyder; Gianrico Farrugia; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-13       Impact factor: 4.052

3.  The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.

Authors:  J A M Smith; D T Beattie; D Marquess; J P Shaw; R G Vickery; P P A Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-16       Impact factor: 3.000

Review 4.  Gut sensing mechanisms.

Authors:  Arushi deFonseka; Jonathan Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2009-12

5.  5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine.

Authors:  Pawan Kumar Shahi; Seok Choi; Dong Chuan Zuo; Cheol Ho Yeum; Pyung Jin Yoon; Jun Lee; Young Dae Kim; Chan Guk Park; Man Yoo Kim; Hye Rang Shin; Hyun Jung Oh; Jae Yeoul Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-06-30       Impact factor: 2.016

6.  Mediation of neurogenic ion transport by acetylcholine, prostanoids and 5-hydroxytryptamine in porcine ileum.

Authors:  DeWayne Townsend; Melissa A Casey; David R Brown
Journal:  Eur J Pharmacol       Date:  2005-09-20       Impact factor: 4.432

7.  A nitrergic secretomotor neurotransmitter in the chloride secretory response to serotonin.

Authors:  Brian N King; Michael C Stoner; Sheikh M Haque; John M Kellum
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

8.  Serotonin and vasoactive intestinal peptide antagonists attenuate rotavirus diarrhoea.

Authors:  S Kordasti; H Sjövall; O Lundgren; L Svensson
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

9.  The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.

Authors:  D T Beattie; J A M Smith; D Marquess; R G Vickery; S R Armstrong; T Pulido-Rios; J L McCullough; C Sandlund; C Richardson; N Mai; P P A Humphrey
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

10.  The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.

Authors:  D T Beattie; S R Armstrong; J P Shaw; D Marquess; C Sandlund; J A M Smith; J A Taylor; P P A Humphrey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.